-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Povorcitinib Phosphate in Vitiligo
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Povorcitinib Phosphate in Vitiligo report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Povorcitinib Phosphate in Vitiligo Drug Details: Povorcitinib (INCB-54707) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – INS-08055 in Idiopathic Pulmonary Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - INS-08055 in Idiopathic Pulmonary Fibrosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. INS-08055 in Idiopathic Pulmonary Fibrosis Drug Details: INS-08055 is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – DNL-788 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DNL-788 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DNL-788 in Amyotrophic Lateral Sclerosis Drug Details: DNL-788 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ISM-012042 in Inflammatory Bowel Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ISM-012042 in Inflammatory Bowel Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ISM-012042 in Inflammatory Bowel Disease Drug Details: ISM012-042 is under...
-
Product Insights
Hypertrophic Scars – Drugs In Development, 2023
Global Markets Direct’s, ‘Hypertrophic Scars - Drugs In Development, 2023’, provides an overview of the Hypertrophic Scars pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hypertrophic Scars, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Kidney Fibrosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Kidney Fibrosis - Drugs In Development, 2023’, provides an overview of the Kidney Fibrosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Kidney Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Female Contraception – Drugs In Development, 2023
Global Markets Direct’s, ‘Female Contraception - Drugs In Development, 2023’, provides an overview of the Female Contraception pipeline landscape. The report provides comprehensive information on the therapeutics under development for Female Contraception, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Focal Segmental Glomerulosclerosis (FSGS) – Drugs In Development, 2023
Global Markets Direct’s, ‘Focal Segmental Glomerulosclerosis (FSGS) - Drugs In Development, 2023’, provides an overview of the Focal Segmental Glomerulosclerosis (FSGS) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Focal Segmental Glomerulosclerosis (FSGS), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Anemia in Chronic Kidney Disease (Renal Anemia) – Drugs In Development, 2023
Global Markets Direct’s, ‘Anemia in Chronic Kidney Disease (Renal Anemia) - Drugs In Development, 2023’, provides an overview of the Anemia in Chronic Kidney Disease (Renal Anemia) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anemia in Chronic Kidney Disease (Renal Anemia), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete...